Ian Driver
Overview
Explore the profile of Ian Driver including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
696
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bae J, Butt A, Labinoti R, Driver I, Malik A
Colorectal Dis
. 2024 Mar;
26(5):1080-1081.
PMID: 38468131
No abstract available.
2.
Abualnaja Y, Driver I, Malik A
Colorectal Dis
. 2024 Feb;
26(3):570-571.
PMID: 38302691
No abstract available.
3.
Woodward O, Driver I, Hart E, Wise R
Cereb Circ Cogn Behav
. 2024 Jan;
6:100196.
PMID: 38179182
The selfish brain mechanism proposes that in some patients with impaired cerebral blood flow (CBF) or cerebrovascular function, hypertension may develop as a compensatory mechanism that aims to maintain CBF...
4.
Lancaster T, Creese B, Escott-Price V, Driver I, Menzies G, Khan Z, et al.
Alzheimers Res Ther
. 2023 Dec;
15(1):213.
PMID: 38087383
Background: Genome-wide association studies demonstrate that Alzheimer's disease (AD) has a highly polygenic architecture, where thousands of independent genetic variants explain risk with high classification accuracy. This AD polygenic risk...
5.
Woodward O, Driver I, Schwarz S, Hart E, Wise R
Br J Radiol
. 2023 Sep;
96(1151):20220940.
PMID: 37721043
MRI offers techniques for non-invasively measuring a range of aspects of brain tissue function. Blood oxygenation level dependent (BOLD) functional magnetic resonance imaging (fMRI) is widely used to assess neural...
6.
Wang S, Li K, Pickholz E, Dobie R, Matchett K, Henderson N, et al.
Sci Transl Med
. 2023 Jan;
15(677):eadd3949.
PMID: 36599008
Advanced hepatic fibrosis, driven by the activation of hepatic stellate cells (HSCs), affects millions worldwide and is the strongest predictor of mortality in nonalcoholic steatohepatitis (NASH); however, there are no...
7.
Lu D, Wu H, Driver I, Ingersoll S, Sohn S, Wang S, et al.
Life Sci Alliance
. 2020 Apr;
3(5).
PMID: 32269069
The therapeutic expansion of Foxp3 regulatory T cells (Tregs) shows promise for treating autoimmune and inflammatory disorders. Yet, how this treatment affects the heterogeneity and function of Tregs is not...
8.
Kim A, Han C, Driver I, Olow A, Sewell A, Zhang Z, et al.
J Immunol
. 2019 Sep;
203(7):2023-2024.
PMID: 31471523
No abstract available.
9.
Kim A, Han C, Driver I, Olow A, Sewell A, Zhang Z, et al.
J Immunol
. 2019 Jun;
203(4):1076-1087.
PMID: 31253728
Elicitation of tumor cell killing by CD8 T cells is an effective therapeutic approach for cancer. In addition to using immune checkpoint blockade to reinvigorate existing but unresponsive tumor-specific T...
10.
Nguyen Q, Pervolarakis N, Blake K, Ma D, Davis R, James N, et al.
Nat Commun
. 2018 May;
9(1):2028.
PMID: 29795293
Breast cancer arises from breast epithelial cells that acquire genetic alterations leading to subsequent loss of tissue homeostasis. Several distinct epithelial subpopulations have been proposed, but complete understanding of the...